Navigation Links
Prostate Cancer Stimulates Nerve Growth
Date:12/3/2008

And this phenomenon is tied to more aggressive disease, researchers say

WEDNESDAY, Dec. 3 (HealthDay News) -- Prostate cancer can promote the growth of new nerves that are associated with more aggressive tumors, U.S. researchers report.

It's been shown that prostate cancer follows the growth of nerves, but this is the first study to find that prostate tumors actually promote nerve growth, says a team at Baylor College of Medicine, Houston. The new finding is comparable to the discovery that tumors promote the growth of new blood vessels (angiogenesis) to nourish themselves, the team said.

"This is the first report of this phenomenon. It represents an important new target in prostate cancer treatment, as prostate cancers are more aggressive when neurogenesis is present," study first author Dr. Gustavo Ayala, a professor of pathology and urology, said in a college news release.

The researchers calculated the density of nerves in human prostate tissues from prostate cancer patients and from people who died of other conditions. They found that nerve density was much higher in those with prostate cancer and precancerous lesions versus those without.

Ayala and colleagues also created a 3-D computer model that simulated the growth of nerves and axons (which carry nerve messages) in prostate cancer. They also found that blocking a protein called semaphorin 4F prevented the growth of new nerves and axons.

The study was published this week in the journal Clinical Cancer Research.

The Baylor team believes that the nerve growth they found in prostate tumors also may occur in other types of cancers.

More information

The American Cancer Society has more about prostate cancer.



-- Robert Preidt


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Prostate cancer drug reduces testosterone levels in as little as 3 days
2. EIN News Introduces Prostate Cancer News Today; Website Offers Information on Risk Factors, Treatment, Drugs
3. USHIFU Announces First Sonablate(R) HIFU Device in India for Minimally Invasive Prostate Cancer Treatment
4. ProstateCradle.com Launches the First “External Prostate Massager” by Enviromax, a Sensational Way to Help Millions of Men Have Healthier Prostate Glands
5. USC researchers identify novel approach for suppressing prostate cancer development
6. World-Renowned Urologist, J. Francois Eid, M.D., Expands Practice with Increased Treatment of Benign Prostate Hyperplasia (BPH)
7. Gene Screen Might Predict Prostate Cancer
8. Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
9. Debiopharm Announces U.S. NDA Filing of Trelstar(R) 6-Month Formulation for Locally Advanced or Metastatic Prostate Cancer
10. Relationship between prostate information and lower urinary-tract symptoms evident
11. Statins Lower Blood Marker for Prostate Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Prostate Cancer Stimulates Nerve Growth
Prostate Cancer Stimulates Nerve Growth
(Date:11/27/2009)...v. 27 Shamir Optical Ind...g provider of innovative products and technology t... its board of directors had declared a dividend di...n (approximately NIS 37.62 million based on the No...or approximately US$ 0.609 (approximately NIS 2.3 ...
(Date:11/27/2009)...medical, economic burdens, study predicts , ...er of people with diabetes in the United States is...study predicts. , That would bring the total by...e, up from 23.7 million today. , , At the same t...l triple, the study also warns, rising from an est...
(Date:11/27/2009)...se bilingual coloring books designed for children ...munity to educate - inform parents and children al... Dinosuars to ABC,S and a host of other topics. ,...ovember 27, 2009 -- Today’s children have en...y any hour of the day, but one of the oldest and s...
(Date:11/26/2009)...wire/ -- With cold and flu season upon us, it,s mo... control the spread of infections and avoid illnes... ourselves healthy, but to avoid transmitting illn...IC (certified in infection-control), nursing direc...at Hospital for Special Surgery (HSS) in Manhattan...
(Date:11/26/2009)...hiomolybdate (TM) has been shown in studies to be ...sease caused by an overload of copper, and certain...le, however, is known about how the drug works at ...estern University researchers now has provided an ...f TM bound to copper-loaded metallochaperones. The...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
... HANOVER, N.H. A new Web site designed to emphasiz...ched through Children,s Hospital at Dartmouth (CHa...nline patient education site was created by Dartmo...grant, the siteNo Smoking Room.Org ( www.nosmoking...
...HESDA, Md., Nov. 13 The fourth annual EagleBank,F...over $100,000. The,following local hospitals were ...ospital and Suburban Hospital in Montgomery County... Primary Care,Coalition of Montgomery County. The ...
...KONKOMA, N.Y., Nov. 13 NBTY, Inc. (NYSE:,NTY) (h...r and marketer of,nutritional supplements, today a...mber of its Board of Directors, has adopted a pre-...he stock,trading plan was adopted in accordance wi...
...T LAUDERDALE, Fla., Nov. 13 eDiets.com,Inc. (Nasd...ome diet, fitness,and healthy lifestyle solutions,... nine months ended September 30, 2008., Revenues ...0.13) per diluted share, for the third quarter of ...
... DIEGO, Nov. 13, 2008 Amylin,Pharmaceuticals, Inc...d,Capital Markets Healthcare Conference in New Yor... Daniel M. Bradbury, president and chief executive...ilable following the event. The Web cast and recor...
...avioral counseling needs to go beyond merely urgin...DAY, Nov. 13 (HealthDay News) -- Teenage girls tre...highly vulnerable to sexually transmitted infectio...earchers, suggest that treating PID "with a prescr...
Other Medicine News:Health News:Innovative new Web site empowers young girls to live smoke-free 2Health News:Fourth Annual EagleBank Foundation Fight Breast Cancer Golf Classic Raises Over $100,000 2Health News:NBTY Founder Adopts Rule 10b5-1 Trading Plan 2Health News:eDiets.com(R) Announces Q3 2008 Results 2Health News:eDiets.com(R) Announces Q3 2008 Results 3Health News:eDiets.com(R) Announces Q3 2008 Results 4Health News:eDiets.com(R) Announces Q3 2008 Results 5Health News:eDiets.com(R) Announces Q3 2008 Results 6Health News:eDiets.com(R) Announces Q3 2008 Results 7Health News:Pelvic Inflammation Puts Girls at Risk for Repeat STIs 2
(Date:11/27/2009)...27 ACUO TECHNOLOGIES, developers o...re, data migration tools and services, is pleased ...emark Office has approved a patent application for...Network." Acuo Technologies is pleased to add the ...rty. In general, the granted patent application br...
(Date:11/25/2009)...Nov. 25 Praxis Electronic Medical ...can Academy of Family Physicians, (AAFP) Family Pr... Survey for improving medical quality, health main...new ARRA Stimulus legislation. Praxis also ranked ...ve effect in determining their salary. Finally, Pr...
(Date:11/25/2009)... 25 Hologic, Inc. (Holog...eloper, manufacturer and supplier of premium diagn...cts dedicated to serving the healthcare needs of w...cal Society of North America (RSNA) at McCormick P...009 to highlight our new SecurView(®) DX mult...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4Gerton Lab determines the composition of centromeric chromatin 10126 1Gerton Lab determines the composition of centromeric chromatin 10126 2William Fuchs Named to PerfectServe Advisory Board 58395 1William Fuchs Named to PerfectServe Advisory Board 58395 2California Cancer Specialists Medical Group Inc finds clinical benefit in RapidArc 28TM 29 technology and executes strategic vendor agreement with V 58392 1California Cancer Specialists Medical Group Inc finds clinical benefit in RapidArc 28TM 29 technology and executes strategic vendor agreement with V 58392 2
...n Phase 1/2 Trial of TRU-016, Trubion,s Proprietar...BI-087 for RA Expands Trubion,s Family of Customiz...ct Candidates, SEATTLE, March 27 Trubion Pharmac...t it has initiated a Phase 1/2,clinical trial of T...ar,ImmunoPharmaceutical (SMIP(TM)) drug candidate,...
... Encouraging Response in CF Patients - Results Va... Model, BETHESDA, Md., March 27 The Cystic Fibro...l drug in development that targets a,basic defect ...e 2a,clinical trial for patients who carry the G55...Vertex Pharmaceuticals Incorporated., Patients wh...
Other Medicine Technology:Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 2Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 3Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 4Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 5Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF 2Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF 3
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: